Almanack Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
10,554
+9,128
| +640% | +$1.69M | 0.31% | 45 |
|
|
2025
Q1 | $299K | Buy |
1,426
+7
| +0.5% | +$1.47K | 0.06% | 115 |
|
|
2024
Q4 | $252K | Hold |
1,419
| – | – | 0.04% | 155 |
|
|
2024
Q3 | $280K | Buy |
+1,419
| New | +$280K | 0.04% | 149 |
|
|
2022
Q4 | – | Sell |
-1,770
| Closed | -$238K | – | 173 |
|
|
2022
Q3 | $238K | Sell |
1,770
-4,887
| -73% | -$657K | 0.05% | 125 |
|
|
2022
Q2 | $1.02M | Buy |
6,657
+3,328
| +100% | +$510K | 0.1% | 136 |
|
|
2022
Q1 | $540K | Buy |
3,329
+143
| +4% | +$23.2K | 0.05% | 246 |
|
|
2021
Q4 | $431K | Sell |
3,186
-179
| -5% | -$24.2K | 0.03% | 286 |
|
|
2021
Q3 | $363K | Buy |
3,365
+315
| +10% | +$34K | 0.03% | 329 |
|
|
2021
Q2 | $344K | Sell |
3,050
-486
| -14% | -$54.8K | 0.03% | 292 |
|
|
2021
Q1 | $383K | Buy |
3,536
+825
| +30% | +$89.4K | 0.04% | 279 |
|
|
2020
Q4 | $291K | Sell |
2,711
-7,494
| -73% | -$804K | 0.03% | 290 |
|
|
2020
Q3 | $1.02M | Buy |
10,205
+811
| +9% | +$81.1K | 0.13% | 105 |
|
|
2020
Q2 | $922K | Buy |
+9,394
| New | +$922K | 0.16% | 70 |
|
|
2019
Q3 | – | Sell |
-1,945
| Closed | -$141K | – | 231 |
|
|
2019
Q2 | $141K | Buy |
+1,945
| New | +$141K | 0.03% | 224 |
|
|
2019
Q1 | – | Sell |
-1,156
| Closed | -$107K | – | 144 |
|
|
2018
Q4 | $107K | Sell |
1,156
-72
| -6% | -$6.66K | 0.03% | 228 |
|
|
2018
Q3 | $108K | Sell |
1,228
-1,442
| -54% | -$127K | 0.03% | 254 |
|
|
2018
Q2 | $247K | Sell |
2,670
-112
| -4% | -$10.4K | 0.11% | 83 |
|
|
2018
Q1 | $263K | Buy |
2,782
+1
| +0% | +$95 | 0.1% | 85 |
|
|
2017
Q4 | $269K | Buy |
2,781
+322
| +13% | +$31.1K | 0.11% | 92 |
|
|
2017
Q3 | $219K | Sell |
2,459
-638
| -21% | -$56.8K | 0.11% | 86 |
|
|
2017
Q2 | $225K | Buy |
+3,097
| New | +$225K | 0.13% | 106 |
|